Active antitumor immunotherapy, with or without B7-mediated costimulation, increases tumor progression in an immunogenic murine T cell lymphoma model
Data up to Jan 2025
Total Citations Per Year
Abstract
References (25)
Enhancement of Antitumor Immunity by CTLA-4 Blockade
1996 • 3,585 citations
CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
1995 • 2,090 citations
CTLA-4 is a second receptor for the B cell activation antigen B7.
1991 • 1,662 citations
Clonal Expansion Versus Functional Clonal Inactivation: A Costimulatory Signalling Pathway Determines the Outcome of T Cell Antigen Receptor Occupancy
1989 • 1,512 citations
Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma Cells
1993 • 1,154 citations
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
1995 • 1,097 citations
Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4
1992 • 1,076 citations
Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function.
1994 • 681 citations
CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL.
1995 • 489 citations
Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity.
1994 • 482 citations
CD28-B7 interactions in T-cell activation
1994 • 315 citations
Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules.
1993 • 274 citations
T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells.
1994 • 174 citations
Costimulation of tumor-reactive CD4+ and CD8+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma.
1994 • 145 citations
Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules.
1995 • 133 citations
Signals involved in T cell activation. T cell proliferation induced through the synergistic action of anti‐CD28 and anti‐CD2 monoclonal antibodies
1988 • 128 citations
Migration Patterns of Dendritic cells in the Mouse
1988 • 105 citations
Effector T‐Cell Induction and T‐Cell Memory versus Peripheral Deletion of T Cells
1993 • 87 citations
Association between MHC class I antigen expression and malignancy of murine T lymphoma variants.
1990 • 20 citations
Modulation of T‐cell responsiveness during Trypanosoma cruzi infection: analysis in different lymphoid compartments
1994 • 18 citations
Immune surveillance: Both CD3+ CD4+ and CD3+ CD8+ T cells control in vivo growth of P815 mastocytoma
1990 • 16 citations
Tumorigenicity of mouse T lymphoma cells is controlled by the level of major histocompatibility complex class I H-2Kk antigens
1994 • 15 citations
Metastasis of mouse T lymphoma cells is controlled by the level of major histocompatibility complex class I H‐2DK antigens
1994 • 12 citations
Limited T cell antigen receptor repertoire in tumor-infiltrating lymphocyte and inhibition of experimental lung metastasis of murine melanoma by anti-TCR antibody.
1995 • 11 citations
Immunogenization of a murine T-cell lymphoma via transfection with interferon-gamma.
1995 • 10 citations